Exeliom Biosciences

Microbiome-based immunotherapy company developing live biotherapeutic products that leverage the gut microbiome to enhance cancer immunotherapy responses.

Location
Lyon, France
Founded
2016
Investors
1
Categories
biotech, microbiome, immunotherapy, oncology, clinical-stage

Investors

NameLocationTypeStagesPortfolio
CE-Ventures (Crescent Enterprises)Sharjah, UAEgeneralist
seedseries-a+3
4